Page last updated: 2024-09-05

diflomotecan and Astrocytoma, Grade IV

diflomotecan has been researched along with Astrocytoma, Grade IV in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bates, SE; Guirouilh-Barbat, J; Liao, Z; Polgar, O; Pommier, Y; Robey, RW; To, KK	1

Other Studies

1 other study(ies) available for diflomotecan and Astrocytoma, Grade IV

Article	Year
Reduced expression of DNA topoisomerase I in SF295 human glioblastoma cells selected for resistance to homocamptothecin and diflomotecan. Molecular pharmacology, 2008, Volume: 73, Issue:2 Topics: Camptothecin; Cell Line, Tumor; DNA Topoisomerases, Type I; Down-Regulation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Enzymologic; Glioblastoma; Humans; Topoisomerase I Inhibitors	2008

Article

Year

Reduced expression of DNA topoisomerase I in SF295 human glioblastoma cells selected for resistance to homocamptothecin and diflomotecan.

Molecular pharmacology, 2008, Volume: 73, Issue:2

Topics: Camptothecin; Cell Line, Tumor; DNA Topoisomerases, Type I; Down-Regulation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Enzymologic; Glioblastoma; Humans; Topoisomerase I Inhibitors

2008